Head and Neck Cancer Trial, Recruiting NCT04671940 Sponsor: Royal Marsden NHS Foundation Trust Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT04671940
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years old
  • People who have previously had a head and neck cancer that was treated with radiation therapy
  • People who are having a type of throat surgery (performed with a robot through the mouth) as part of their treatment for a head and neck cancer that has come back, not fully gone away, or is a new cancer in the same area

Who may not be able to join:

  • People whose robotic mouth surgery is being done only to investigate or diagnose cancer, rather than as part of treatment
  • People whose head and neck cancer is located in the upper throat (behind the nose) or in the thyroid gland
  • People in the retrospective (past records) part of the study where no stored tissue samples are available from their returning or remaining tumour

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Prof Vinidh Paleri, The Royal Marsden Hospital NHS Foundation Trust

Phone: 442073528171

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Royal Marsden NHS Foundation Trust
Registry
ClinicalTrials.gov
Start date
18 November 2020
Est. completion
7 October 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Identification of resistant sub clones in post radiotherapy tumour samples

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov